Drug Type Small molecule drug |
Synonyms |
Action antagonists |
Mechanism NK1R antagonists(Neurokinin 1 receptor antagonists), Neuropeptide receptor antagonists |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H29F3N2O2 |
InChIKeyODEBBNRINYMIRX-ACIOBRDBSA-N |
CAS Registry225655-10-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chemotherapy-induced nausea and vomiting | Phase 2 | Japan | 01 Aug 2008 | |
Depressive Disorder | Phase 2 | - | - |